Study of Radiation Therapy Alone or in Combination with Chemotherapy for Patients with Non-Small Cell Lung Cancer
Research committees
Publication Information Expand/Collapse
2012
2000
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
1997
Induction cisplatin/vinblastine and irradiation vs irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in RTOG 88-08/ECOG 4588.
Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with hyperfractionated radiotherapy with/without chemotherapy: A multivariate analysis of 682 RTOG Patients.
Response, toxicity, failure patterns and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy (CT) and radiation therapy (RT) for locally advanced non-small cell lung carcinoma of the lung (NSCLC).
Intensified treatment increases survival in patients with non-small cell lung cancer at what place? A quality adjusted survival analysis of radiation therapy oncology group chemoradiation studies.
Addition of chemotherapy to radiation therapy alter failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of radiation therapy oncology group (RTOG) trials.
Toxicity in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy (CT) radiation therapy (RT) for locally advanced non-small cell carcinoma of the lung (NSCLC).
Response, failure patterns and survival in five radiation therpay oncology group (RTOG) trials of sequential and/or concurrent chemotherpy (CT) radiation therapy (RT) for locally advanced non-small cell carcinoma of the lung (NSCLC).
1996
Induction cisplatin/vinblastine decreased distant metastasis in unresectable squamous cell lung cancer (SCC): Failure patterns.
New Chemotherapy/radiation therapy regimens may improve survival for patients with locally advanced unresectable non-small cell lung cancer.
1995
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer.
RTOG 8808 ECOG 4588, Preliminary analysis of a phase III trial in regionally advanced unresectable non-small cell lung cancer with minimum three year follow-up.
Response to induction chemotherapy does not predict for long term survival among patients with unresected stage III non-small cell lung cancer (NSCLC) receiving sequential chemo-radiation on RTOG 8804 and 8808.
1994
RTOG 8808 ECOG 4588, Preliminary analysis of phase III trial in regionally advanced unresectable non-small cell lung cancer.
RTOG 8808 ECOG 4588, Preliminary analysis of a phse III trial in regionally advanced unresectable non-small cell lung cancer.